Prevention of HIV/AIDS among injecting drug users in Russia: Opportunities and barriers to scaling-up of harm reduction programmes

Health Policy

Volumn 85, Issue 2, 2008, Pages 162-171

  Tkatchenko Schmidt, Elena ^a   Renton, Adrian ^a   Gevorgyan, Ruzanna ^b   Davydenko, Ludmila ^c   Atun, Rifat ^d  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^c VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CIS; Harm reduction; HIV AIDS; Russia; Scale up

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG USE; FINANCIAL MANAGEMENT; GOVERNMENT; HARM REDUCTION; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION; INJECTION; LAW ENFORCEMENT; LEGAL ASPECT; RUSSIAN FEDERATION; SCALE UP; SEMI STRUCTURED INTERVIEW;

HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; RISK REDUCTION BEHAVIOR; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 37349014073     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2007.07.005     Document Type: Article

References (88)

1. Riley D., and O-Hare P. Harm reduction: history, definition and practice. In: Inciardi J.A., and Harrison L.D. (Eds). Harm reduction: national and international perspectives. (1999), Sage Publications, Newbury Park 1-26
2. Burrows D. Starting and managing needle and syringe programmes: a guide for central and eastern Europe/newly independent states (2000), Open Society Institute, New York
3. World Health Organisation. Biregional Strategy for Harm Reduction 2005-2009. HIV and Injecting Drug Use. Geneva; 2005.
4. Stimson G.V. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Social Science & Medicine 5 (1995) 699-716
5. Hurley S., Jolly D.J., and Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet 349 (1997) 1797-1800
6. Gibson D.R., Flynn N.M., and Perales D. Effectiveness of syringe exchange programmes in reducing HIV risk behaviour and HIV seroconversion among injecting drug users. AIDS 15 (2001) 1329-1341
7. Azim T., Hussein N., and Kelly R. Effectiveness of harm reduction programmes for injecting drug users in Dhaka city. Harm Reduction Journal 2 (2005) 22
8. World Health Organisation, United Nations Office for Drugs and Crime, United Nations Joint Programme on HIV/AIDS. Reduction of HIV Transmission through Outreach. Policy Brief. Geneva; 2004.
9. DeJong J.A. Question of scale: the challenges of expanding the impact of non-governmental organisations' HIV/AIDS efforts in developing countries (2001), Horizons/International AIDS Alliance, London
10. United Nations Joint Programme on HIV/AIDS. Preventing the Transmission of HIV among Drug Abusers. A Position Paper of the United Nations System. Geneva; 2000.
11. International Harm Reduction Development Programme Harm Reduction Developments 2005. New York: Open Society Institute; 2005.
12. Burrows D. Strategies for Scaling-up HIV Prevention in Russian Federation. Working Paper; 2002.
13. United Nations Joint Programme on HIV/AIDS. Intensifying HIV Prevention. Position Paper. Geneva; 2005.
14. World Bank. The World Bank's HIV/AIDS Program of Action. Washington; 2005.
15. World Health Organisation/United Nations Office on Drugs and Crime/United Nations Joint Programme on HIV/AIDS. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: Position Paper. Geneva; 2004.
16. Rhodes T., Ball A., Stimson G.V., Kobyshcha Y., Fitch C., Pokrovsky V., et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction 94 (1999) 1323-1336
17. Grassly N.C., Lowndes C.M., Rhodes T., Judd A., Renton A., and Garnett G.P. Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India. International Journal of Drug Policy 14 (2003) 25-43
18. Kelly J.A., and Amirkhanian Y.A. The newest epidemic: a review of HIV/AIDS in central and eastern Europe. International Journal of STD & AIDS 14 (2003) 361-371
19. Rhodes T., Sarang A., Bobrik A., Bobkov E., and Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. International Journal of Drug Policy 15 (2004) 1-16
20. Central and Eastern European Harm Reduction Network. Injecting Drug Users, HIV/AIDS Treatment and Primary Care in Central and Eastern Europe and the Former Soviet Union. Vilnus; 2002.
21. Ivanov I. The research in Tver (Russia) on injecting drug users' sexual behavior. XIV International AIDS Conference. Barcelona, Spain, 7-12 July (2002) Abstract II:497
22. Hide L. Entering the community of injecting drug users: secondary needle exchange in the Far East of Russia. Outreach 1 (2004) 9-11
23. Moshkovich G.F. Implementation of the harm reduction programme in Nizhny Novgorod. Krugly Stol (Round Table) 5 (2001) 48-55
24. Donoghoe MC. Injecting drug use, harm reduction and HIV/AIDS. In Martic S., Lazarus JV, Donoghoe MC, editors. HIV/AIDS in Europe: moving from death sentence to chronic disease management. Copenhagen; 2006.
25. Donoghoe M.C., Lazarus J.V., and Matic S. HIV/AIDS in the transitional countries of eastern Europe and central Asia. Clinical Medicine 5 (2005) 487-490
26. Open Health Institute. Rapid Assessment of Harm Reduction Coverage in 15 Russian Cities (unpublished report); 2004.
27. Russian Harm Reduction Network. Annual Report 2005. Moscow; 2005.
28. Sanitary and Epidemiology Service Ministry of Health. Decree of the Chief Sanitary Doctor of the Russian Federation on intensifying actions in HIV prevention and control; February 2002.
29. Federal Service for control of consumer rights and wellbeing Ministry of Health. Decree of the Chief Sanitary Doctor of the Russian Federation on intensifying actions in HIV prevention and control; May 2005.
30. Badrieva L. Harm reduction projects under the policy of elimination of drug abuse: peculiarities of work in Kazan. Paper presented at the Global Research Network Meeting, Melbourne, 11-12 October 2001.
31. Butler WE. HIV/AIDS and drug misuse in Russia: harm reduction programmes and the Russian legal system. London; 2003.
32. Oleynik S. Defence of harm reduction programmes in courts. Harm Reduction in Russia 17 (2006) 12-13
33. World Health Organisation. WHO Model List of Essential Medicines. 14th ed.; March 2005.
34. United Nations Joint Programme on HIV/AIDS. 2004 Report on the Global HIV/AIDS Epidemic: 4th Global Report. Geneva; 2004.
35. United Nations Development Programme. HIV/AIDS in Eastern Europe and the Commonwealth of Independent States: Reversing the Epidemic. Facts and Policy Options. Bratislava; 2004.
36. Walt G. Health policy. An introduction to process and power (1994), Zed Books, London
37. Parsons W. Public policy. An introduction to the theory and practice of policy analysis (1995), Edward Elgar, Chettenham
38. Hay C. Political analysis. A critical introduction. (2002), Pelgrave Macmillan, New York
39. In: Mann J., Tarantola D.J.M., and Netter T.W. (Eds). AIDS in the world. A global report (1992), Harvard University Press, Cambridge
40. Barnett T., and Whiteside A. AIDS in the twenty-first century: disease and globalisation (2002), Pelgrave Macmillan, Basingstoke
41. Holden S. AIDS on the agenda. Adapting development and humanitarian programmes to meet the challenges of HIV/AIDS (2003), Oxfam, Oxford
42. Goscomstat. Russia in figures. Moscow: Goscomstat; 2003.
43. AIDS Foundation East-West. HIV/AIDS in Russia Updates, www.afew.org; 2004.
44. Focus-media. HIV/AIDS Statistics 2005, www.focus-media.ru; 2005.
45. Kickert J.M., Klijn E.H., and Koppenjan J.F.M. Introduction: a management perspective on policy networks. In: Kickert J.M., Klijn E.-., and Koppenjan J.F.M. (Eds). Managing complex networks: strategies for the public sector (1999), Sage Publications, London
46. Levine S., and White P.E. Exchange as a conceptual framework for the study of interorganisational relationships. Administrative Science Quarterly 5 (1961) 583-601
47. Aiken M., and Hage J. Organisational interdependence and intra-organisational structure. American Sociological Review 33 (1967) 912-930
48. Mays N., and Pope C. Qualitative research: rigour and qualitative research. British Medical Journal 311 (1995) 109-112
49. Seale C., and Silverman D. Ensuring rigour in qualitative research. European Journal of Public Health 7 (1997) 379-384
50. UNAIDS 2006 Report on the global AIDS epidemic. Geneva: UNAIDS, WHO; 2006.
51. AIDS Foundation East-West. HIV/AIDS in Russia Updates, www.afew.org; 2007.
52. World Bank. Combating HIV/AIDS in Europe and Central Asia. Washington; 2005.
53. Platt L., Hickman M., Rhodes T., Mikhailova L., Karavashkin V., Vlasov A., et al. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. Addiction 99 (2004) 1430-1438
54. Rhodes T., Platt L., Judd A., et al. Prevalence of hepatitis C infection, and co-infection with HIV, among injecting drug users in Togliatti City, Russia. International Journal of STD & AIDS 16 (2005) 749-754
55. Hall P., Land H., Parker R., and Webb A. Change choice and conflict in social policy (1975), Heinemann, London
56. Kingdon J. Agendas, alternatives and public policies (1984), Little Brown & Co., Boston
57. Ham C., and Hill M. The policy process in the modern capitalist state (1986), Wheatsheaf, Sussex
58. Rhodes T. The 'risk environemnt': a framework for understanding and reducing drug-related harm. International Journal of Drug Policy 13 (2002) 85-94
59. Atun R.A., McKee M., Drobniewski F., and Coker R. Analysis of how health system context influences HIV control: case studies from the Russian Federation. Bulletin of the World Health Organisation 83 (2005) 730-738
60. Mounier S., McKee M., Atun R.A., and Coker R. HIV/AIDS in Central Asia. In: Twigg J.L. (Ed). HIV/AIDS in Russia and Eurasia vol. II (2007), Palgrave McMillan, New York
61. Rhodes T., Mikhailova L., Sarang A., et al. Situational factors associated with drug injecting, risk reduction and syringe exchange practices in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Social Science and Medicine 57 (2003) 39-54
62. Curtis S., Petukhova N., and Taket A. Health care reforms in Russia: the example of St. Petersburg. Social Science and Medicine 40 6 (1995) 755-765
63. Burger E.J., Field M.G., and Twigg J.L. From assurance to insurance in Russian health care: the problematic transition. American Journal of Public Health 88 (1998) 755-758
64. Tkatchenko E., McKee M., and Tsouros A.D. Public health in Russia: the view from inside. Public health, Policy and Planning 15 2 (2000) 164-169
65. Shevchenko Y. Physician and the state, healthcare and morale, medicine and law. Ekonomika zdravoohranenia (1999) 11-12
66. Ministry of Health of Russian Federation. Official Documents and papers on HIV/AIDS. Collection of publications. Moscow: Ministry of Health; 1998.
67. World Health Organisation. Summary country profile for HIV/AIDS treatment scale up. Russian Federation; December 2005.
68. World Bank. Russian Economic Report; November 2004.
69. World Bank. Russian Economic Report; November 2005.
70. World Bank. Russian Economic Report; April 2006.
71. Alcorn K. Russia to step up AIDS funding, will cover Global Fund grants in country. AIDS Map News (July 17, 2006)
72. Wolfe D. Opportunities lost. HIV prevention, harm reduction, and the Russian funding gap. Update from International Harm Reduction Development Programme; August 31, 2005.
73. Open Health Institute. Harm Reduction programs in the civilian and prison sectors of the Russian Federation: assessment of best practices. Moscow: Open Health Institute; 2006.
74. Klomegah KK. More funding, but HIV/AIDS on the rise. Inter Press services news; June 3, 2007.
75. Lazzarini Z. Rapid assessment of drug law and policy in the CEE and FSU, unpublished.
76. Wood E., and Kerr T. Measuring the public health impact of police activities on illicit drug users. International Journal of Drug Policy 16 3 (2005) 148-149
77. Sibeon R. Contemporray sociology and policy analysis. (1988), Tudor Business, Merseyside
78. Heywood A. Politics (1997), Pelgrave McMillan, New York
79. Des Jarlais D.C., Friedmann P., Grund J., Milliken J., Titus S., Zadoretzky C., et al. HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia. International Journal of Drug Policy 13 (2002) 165-170
80. MacMaster S.A., and Womack B.G. HIV prevention for active injection drug users: a brief history of syringe exchange programmes. Journal of HIV/AIDS and Social Service 1 (2002) 95-112
81. Rhodes T., Platt L., Sarang A., et al. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative case study of police perspectives. Journal of Urban Health 83 (2006) 911-925
82. Habib S.E., Adorjany L.V., and Hepatitis C. and injecting drug use: the realities of stigmatisation and discrimination. Health Education Journal 62 (2003) 256-265
83. Hacker M.A., Malta M., Enriquez M., and Bastos F.I. Human Immunodeficiency virus, AIDS, and drug consumption in South America and the Caribbean: epidemiological evidence and initiatives to curb the epidemic. Pan American Journal of Public Health 18 (2005) 303-313
84. Kon I. The sexual revolution in Russia: from the age of czars to today (1995), the Free Press, London
85. Hunt N., Trace M., and Bewley-Taylor D. Reducing drig-related harms to health: an overview of the global evidence. The Berkley Foundation Drug Policy Programme Report (2004)
86. Unuted Nations Joint Programme on HIV/AIDS Innovative approaches to HIV prevention: selected case studies. Geneva: UNAIDS; 2000.
87. World Health Organisation. Evidence for action: effectiveness of community-based outreach in preventing HIV/AIDS among injective drug users. Geneva: WHO; 2004.
88. WHO, UNAIDS, UNODC Policy brief: reduction of HIV transmission through outreach. Geneva: WHO; 2004.